Shire plc Makes $750 Million Regenerative Medicines Buy More...
Stryker Corporation (SYK) to Axe 142 Jobs As Plants Merge More...
• Tryton Medical, Inc. Announces CE Mark for Larger-Diameter Sizes of Side Branch Stent More...
• BIOTRONIK Announces Positive 6-Month Results for DREAMS, the Pioneering Drug-Eluting Absorbable Metal Scaffold More...
• Michael Garippa Announced as SynCardia Systems, Inc.'s New CEO More...
• Thermo Fisher Scientific (TMO) Acquires Leading UK Provider of Laboratory Specialty Products, Sterilin, Ltd. More...
• BioLineRx Ltd. Acquires Exclusive License Rights From Algen for Cancer Therapeutic BL-7030 More...
• Pfizer Inc. (PFE) Blames Teva Pharmaceutical Industries Limited (TEVA), IVAX Diagnostics, Inc. for "Billions" in Neurontin Losses More...
• Is Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Finally Set to Buy Nycomed for $12 Billion? - Deal to be Formally Announced Today More..
• Amgen (AMGN) XGEVA Phase 3 Trial Meets Primary Endpoint More..
• Roche (RHHBY) to Present Positive Progress in Skin, Lung, and Ovarian Cancer Drugs at American Society of Clinical Oncology More..
• FDA Issues Shire plc Warning Letter On ADHD Drug Marketing More...
• Pearl Therapeutics' Phase IIb Results Show a 50% Improvement in Lung Function with PT003 Compared to Spiriva(R) and Foradil(R) in Patients with COPD More...
• Astellas Pharma US Announces Positive Phase III Results Showing Mirabegron Improves Key OAB Symptoms More...
• inVentiv Health (VTIV) to Acquire PharmaNet, Inc. as the CRO Consolidation Game Continues More...
Stryker Corporation (SYK) to Axe 142 Jobs As Plants Merge More...
• Tryton Medical, Inc. Announces CE Mark for Larger-Diameter Sizes of Side Branch Stent More...
• BIOTRONIK Announces Positive 6-Month Results for DREAMS, the Pioneering Drug-Eluting Absorbable Metal Scaffold More...
• Michael Garippa Announced as SynCardia Systems, Inc.'s New CEO More...
• Thermo Fisher Scientific (TMO) Acquires Leading UK Provider of Laboratory Specialty Products, Sterilin, Ltd. More...
• BioLineRx Ltd. Acquires Exclusive License Rights From Algen for Cancer Therapeutic BL-7030 More...
| • AEterna Zentaris (AEZS) Reports First Quarter 2011 Financial and Operating Results More.. • Bio-Path Holdings, Inc. (BPTH) Reports First Quarter 2011 Financial Results More... • LecTec Corporation Announces First Quarter Results More... • Patheon (PTI.TO) Announces Date Of Second Quarter Fiscal 2011 Financial Results More... |
0 comments